Aim: This work was designed to investigate the relationship between cardiac outcomes and Naples Prognostic Score (NPS) among heart failure (HF) patients. Materials & methods: This retrospective obs... Plain language summary Heart failure is a serious condition that affects millions of individuals around the world. This study was designed to investigate whether there is a relationship between Nap... Tweetable abstract This study reveals Naples Prognostic Score (NPS) as a strong predictor of mortality and rehospitalization in patients with advanced heart failure. NPS also outperforms other scor...
This study aimed to explore the potential association between the triglyceride–glucose index (TyG) and the atherogenic index of plasma (AIP)—both considered surrogate markers for atherosclerosis—and major adverse cardiovascular events (MACEs) in patients diagnosed with chronic coronary syndrome (CCS). We conducted a retrospective analysis, encompassing 715 consecutive patients with intermediate CCS risk, who presented at the outpatient clinic between June 2020 and August 2022. MACEs included non-fatal myocardial infarction, hospitalization for heart failure, cerebrovascular events, non-cardiac mortality, and cardiac mortality. The primary outcome was the composite occurrence of MACEs during the follow-up period. For time-to-event analysis of the primary outcome, we employed Kaplan–Meier plots and Cox proportional hazard models. The median age of the overall study population was 55 years, with a median follow-up duration of 17 months. Multivariate Cox regression analysis identified age, hypertension, Coronary Artery Disease–Reporting and Data System score, and TyG index as independent predictors of the primary outcome. Notably, individuals with high TyG levels exhibited a significantly higher primary outcome rate compared to those with low TyG levels (18.7% vs. 3.8%, p < 0.001). Similarly, patients with elevated TyG values demonstrated statistically higher rates of cerebrovascular events, hospitalizations for heart failure, non-fatal myocardial infarctions, non-cardiac mortality, and cardiac mortality. These findings suggest that TyG may serve as a predictive marker for adverse cardiovascular outcomes in patients with CCS.
Bu bölümde kronik total oklüzyon(KTO)’lu hastalarda koroner kollaterallerin değerlendirilmesinde kullanılan başlıca görüntüleme yöntemleri olan koroner anjiyografi, intravasküler ultrason (IVUS), kardiyak manyetik rezonans görüntüleme (MRG), koroner bilgisayarlı tomografik anjiyografi (BTA) ve optik koherens tomografi (OCT) ele alınacaktır. Her birinin KTO’lu hastaların koroner kollaterallerinin görüntülemesinde yeri, avantajları, dezavantajları ve birbirine göre üstünlüklerine yer verilecektir. KTO'lu hastalarda kollateral dolaşımın değerlendirilmesinde her yöntemin kendine özgü avantajları ve dezavantajları vardır ve optimal görüntüleme modalitesi klinik duruma, mevcut kaynaklara ve hastanın özelliklerine göre belirlenmelidir. KTO'lu hastalarda en iyi tedavi stratejisini belirlemek için kollateral dolaşımın kapsamlı bir şekilde değerlendirilmesi son derece önemlidir. This section will address the main imaging methods used to evaluate coronary collaterals in patients with chronic total occlusion (CTO), including coronary angiography, intravascular ultrasound (IVUS), cardiac magnetic resonance imaging (MRI), coronary computed tomography angiography (CTA), and optical coherence tomography (OCT). The role of each method in imaging coronary collaterals in CTO patients, along with their advantages, disadvantages, and relative superiority to one another, will be discussed. Each method has its own unique advantages and disadvantages in assessing collateral circulation in patients with CTO, and the optimal imaging modality should be determined based on the clinical situation, available resources, and patient characteristics. A comprehensive evaluation of collateral circulation is crucial for determining the best treatment strategy in patients with CTO.
Aterosklerotik Koroner Arter Hastalığı Tanımı Epidemiyolojisi ve Risk Faktörleri Gazi ÇAPAR Yeliz GÜLER Arter Histolojisi ve Ateroskleroz Patofizyolojisi Hüseyin AKGÜN Ersin İBİŞOĞLU Koroner Kollateral Gelişiminin Fizyolojisi ve Gelişim Mekanizmaları Yusuf İNCİ Koroner Kollateral Gelişimini Etkileyen Faktörler Muhammed Mert GÖKSU Günseli ÜREDİ Ömer GENÇ Kronik Total Oklüzyonlarda Koroner Arter Kollaterallerinin Görüntüleme Yöntemleri Ufuk YILDIZ Koroner Kollateral Dolaşımın Sınıflandırılması Gamze ACAR Furkan ŞEN Ömer GENÇ Kronik Total Oklüzyon Girişimlerinde Kollateral Seçimi Mehmet NAİL BİLEN Kronik Kollateral Damar Geçişlerinde Malzeme Seçimi Ufuk SALİ HALİL Göksenin Cansu ÖZDOĞAN Aslan ERDOĞAN Koroner Kollateral Dolaşım ve Sistemik Hastalıklar Deniz Dilan Naki TEKİN Koroner Arter Hastalığı Olan Erkek Hastalarda Kollateral Dolaşımın Derecesi İle Testosteron ve Dehidroepiandrosteronun Seviyesi Arasındaki İlişkinin Değerlendirilmesi Aslan ERDOĞAN Cevat KIRMA Koroner Kollateral Dolaşımın Önemi ve Güncel Çalışmalar İlyas ÇETİN
Acute ST-elevation myocardial infarction with coronary artery ectasia is rare and difficult to treat. The complication rate is high in percutaneous intervention. At the same time, a standard treatment cannot be performed due to the lack of sufficient studies. In this case, complex complications and a different solution technique are presented. Here, we present our experience with a case of acute inferior myocardial infarction in a 62-year-old man with an ectatic right coronary artery and a 1-year follow-up report.
Background/Objectives: In patients with non-ST-segment elevation myocardial infarction (NSTEMI), contrast-associated acute kidney injury (CA-AKI) is a clinically important complication of coronary angiography. Whether the Fibrosis-4 (FIB-4) index and aspartate aminotransferase-to-platelet ratio index (APRI) relate to CA-AKI in this setting is unclear. We compared the associations of both indices with CA-AKI. Methods: We retrospectively analyzed 771 patients with NSTEMI who underwent coronary angiography from May 2020 to May 2025. CA-AKI was identified from changes in serum creatinine 48–72 h after contrast administration. Both indices were derived from admission laboratory values. Associations were evaluated using separate multivariable logistic regression models. Discrimination was compared using the paired DeLong test, and the incremental performance of FIB-4 beyond the Mehran score was explored. Results: Overall, 97 patients (12.6%) developed CA-AKI. In the primary adjusted model, FIB-4 was associated with CA-AKI (odds ratio 1.19, 95% confidence interval 1.04–1.36; p = 0.013), but APRI was not. FIB-4 showed modest discrimination but a significantly higher area under the receiver operating characteristic curve (AUC) than APRI (0.614 versus 0.535; DeLong p < 0.001). Adding FIB-4 to the Mehran score improved model fit (likelihood-ratio p = 0.009), but the increase in AUC from 0.646 to 0.666 was not statistically significant (DeLong p = 0.100). Sensitivity analyses showed that the association varied with covariate adjustment. Conclusions: FIB-4 was associated with CA-AKI in the primary adjusted model and showed higher discrimination than APRI. These findings support further investigation of FIB-4 as a potential adjunct to renal risk assessment, although its modest discrimination and uncertain incremental clinical value require independent validation.